Colcrys and Patanase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colcrys (colchicine) and Patanase (olopatadine hydrochloride). Common drug interactions include dyspnoea among females and disability among males.

The phase IV clinical study analyzes what interactions people have when they take Colcrys and Patanase. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Colcrys?

Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.

What is Patanase?

Patanase has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 1,514 Patanase users. Check the latest studies of Patanase.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

18 people who take Colcrys and Patanase together, and have interactions are studied.

What are the common drug interactions of Colcrys and Patanase, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Lung disorder (lung disease)
Malaise (a feeling of general discomfort or uneasiness)
Multiple allergies (allergy to multiple agents)
Pericardial effusion (fluid around the heart)
Surgery

male:

Disability
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Onychoclasis (breaking of the nails)
Pain
Post procedural haemorrhage (post procedural bleeding)
Renal cyst (kidney cyst)
Tremor (trembling or shaking movements in one or more parts of your body)
Neuropathy peripheral (surface nerve damage)
Chronic kidney disease
Decreased appetite

What are the common drug interactions of Colcrys and Patanase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood potassium decreased
Dehydration (dryness resulting from the removal of water)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

60+:

Chronic kidney disease
Decreased appetite
Surgery
Memory impairment
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Dyspnoea (difficult or laboured respiration)
Lung disorder (lung disease)
Malaise (a feeling of general discomfort or uneasiness)
Multiple allergies (allergy to multiple agents)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 50.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 33.33%
Allergic Sinusitis: 3 people, 16.67%
Vitamin E Deficiency: 2 people, 11.11%
Inflammation: 2 people, 11.11%
High Blood Cholesterol: 2 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 11.11%
Diabetes: 2 people, 11.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Colcrys and Patanase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously